会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明授权
    • Apparatus and method for prediction and management of participant compliance in clinical research
    • 临床研究参与者依从性预测与管理的装置及方法
    • US07415447B2
    • 2008-08-19
    • US11324504
    • 2006-01-03
    • Saul ShiffmanMichael R. HuffordJean A. Paty
    • Saul ShiffmanMichael R. HuffordJean A. Paty
    • G06F17/00G06N5/00G06N5/02
    • G06Q90/00G06F19/00G06Q10/04G16H10/20G16H40/20
    • A system for developing and implementing empirically derived algorithms to generate decision rules to determine participant noncompliance and fraud with research protocols in clinical trials allows for the identification of complex patterns of variables that detect or predict participant noncompliance and fraud with research protocol, including performance and enrollment goals, in the clinical trial. The data may be used to overall predict the performance of any participant in a clinical trial, allowing selection of participants that tend to produce useful, high-quality results. The present invention can also be used to monitor participant compliance with the research protocol and goals to determine preferred actions to be performed. Optionally, the invention may provide a spectrum of noncompliance, from minor noncompliance needing only corrective feedback, to significant noncompliance requiring participant removal from the clinical trial or from future clinical trials. The algorithms and decision rules can also be domain-specific, such as detecting non-compliance or fraud among subjects in a cardiovascular drug trial, or demographically specific, such as taking into account gender, age or location, which provides for algorithms and decision rules to be optimized for the specific sample of participants being studied.
    • 用于开发和实施经验派生算法以生成决策规则以确定临床试验中的研究协议的参与者违规和欺诈的系统允许通过研究方案来识别检测或预测参与者违规和欺诈的复杂变量模式,包括绩效和注册 目标,在临床试验。 数据可用于总体预测临床试验中任何参与者的表现,允许选择倾向于产生有用的高质量结果的参与者。 本发明还可以用于监视参与者遵守研究协议和目标以确定要执行的优选动作。 任选地,本发明可以从仅需要纠正反馈的轻微不合规性到要求参与者从临床试验或未来临床试验中移除的重大不合规提供一系列不合规。 算法和决策规则也可以是域特定的,例如在心血管药物试验中检测受试者的不合规或欺诈,或人口统计特异性,例如考虑性别,年龄或位置,其提供算法和决策规则 针对正在研究的参与者的具体样本进行优化。